Swiss health care company Roche on Monday announced it would acquire Telavant Holdings in a $7.1 billion transaction.

Was this article helpful?
YesNo

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Close Search Window